Skip to main content
main-content

04.11.2017 | Prevention of Heart Failure (M. St. John Sutton, Section Editor) | Ausgabe 6/2017

Current Heart Failure Reports 6/2017

High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications

Zeitschrift:
Current Heart Failure Reports > Ausgabe 6/2017
Autoren:
Rishi K. Wadhera, Jordan D. Anderson, Robert W. Yeh
Wichtige Hinweise
This article is part of the Topical Collection on Prevention of Heart Failure

Abstract

Purpose of Review

Public reporting of outcomes for percutaneous coronary intervention (PCI) is used in some states to drive improvements in care delivery and performance. However, a growing body of evidence suggests unintended consequences, particularly provider aversion to performing PCI in high-risk patients.

Recent Findings

There is mixed evidence regarding the impact of PCI public reporting on patient outcomes. In addition, providers in public reporting states likely have a higher threshold or potentially avoid performing PCI on high-risk patients, such as those with cardiogenic shock. The exclusion of patients with refractory cardiogenic shock from public reports in New York state has reduced provider risk aversion. Though this represents a step in the right direction, other strategies are needed to diminish continued provider risk aversion and strengthen PCI care quality.

Summary

Public reporting initiatives for PCI are beginning to proliferate nationally. However, the challenge of fostering the positive of aspects of reporting, which incentivize improved care quality and procedural performance, while ensuring that high-risk patients continue to receive appropriate care remains. It is imperative that policymakers and cardiologists continue to develop innovative solutions that address risk aversive provider behaviors towards high-risk patients.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 6/2017

Current Heart Failure Reports 6/2017 Zur Ausgabe

Genetics of Heart Failure (K Adams, Section Editor)

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S Katz, Section Editor)

Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure

Genetics of Heart Failure (K Adams, Section Editor)

Clinical Application of Genetic Testing in Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S Katz, Section Editor)

Skeletal muscle alterations in HFrEF vs. HFpEF

  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Sie können e.Med Allgemeinmedizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise